NM_182914.3:c.399G>C

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_182914.3(SYNE2):​c.399G>C​(p.Leu133Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0794 in 1,578,694 control chromosomes in the GnomAD database, including 6,239 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. L133L) has been classified as Benign.

Frequency

Genomes: 𝑓 0.11 ( 1276 hom., cov: 32)
Exomes 𝑓: 0.076 ( 4963 hom. )

Consequence

SYNE2
NM_182914.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.888

Publications

8 publications found
Variant links:
Genes affected
SYNE2 (HGNC:17084): (spectrin repeat containing nuclear envelope protein 2) The protein encoded by this gene is a nuclear outer membrane protein that binds cytoplasmic F-actin. This binding tethers the nucleus to the cytoskeleton and aids in the maintenance of the structural integrity of the nucleus. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2009]
SYNE2 Gene-Disease associations (from GenCC):
  • autosomal dominant Emery-Dreifuss muscular dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Emery-Dreifuss muscular dystrophy 5, autosomal dominant
    Inheritance: AD, Unknown Classification: LIMITED, NO_KNOWN Submitted by: Illumina, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • left ventricular noncompaction
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.46).
BP6
Variant 14-63942134-G-C is Benign according to our data. Variant chr14-63942134-G-C is described in ClinVar as Benign. ClinVar VariationId is 130496.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.888 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.208 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SYNE2NM_182914.3 linkc.399G>C p.Leu133Leu synonymous_variant Exon 6 of 116 ENST00000555002.6 NP_878918.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SYNE2ENST00000555002.6 linkc.399G>C p.Leu133Leu synonymous_variant Exon 6 of 116 1 NM_182914.3 ENSP00000450831.2 Q8WXH0-2A0A0C4DGK3

Frequencies

GnomAD3 genomes
AF:
0.111
AC:
16844
AN:
151998
Hom.:
1271
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.211
Gnomad AMI
AF:
0.0450
Gnomad AMR
AF:
0.120
Gnomad ASJ
AF:
0.0530
Gnomad EAS
AF:
0.0521
Gnomad SAS
AF:
0.0387
Gnomad FIN
AF:
0.0375
Gnomad MID
AF:
0.0348
Gnomad NFE
AF:
0.0734
Gnomad OTH
AF:
0.0891
GnomAD2 exomes
AF:
0.0847
AC:
21015
AN:
248130
AF XY:
0.0776
show subpopulations
Gnomad AFR exome
AF:
0.222
Gnomad AMR exome
AF:
0.165
Gnomad ASJ exome
AF:
0.0515
Gnomad EAS exome
AF:
0.0414
Gnomad FIN exome
AF:
0.0432
Gnomad NFE exome
AF:
0.0717
Gnomad OTH exome
AF:
0.0738
GnomAD4 exome
AF:
0.0761
AC:
108526
AN:
1426578
Hom.:
4963
Cov.:
27
AF XY:
0.0738
AC XY:
52550
AN XY:
711984
show subpopulations
African (AFR)
AF:
0.221
AC:
7176
AN:
32530
American (AMR)
AF:
0.158
AC:
7054
AN:
44662
Ashkenazi Jewish (ASJ)
AF:
0.0515
AC:
1336
AN:
25946
East Asian (EAS)
AF:
0.0734
AC:
2899
AN:
39482
South Asian (SAS)
AF:
0.0377
AC:
3226
AN:
85630
European-Finnish (FIN)
AF:
0.0434
AC:
2256
AN:
51946
Middle Eastern (MID)
AF:
0.0255
AC:
145
AN:
5688
European-Non Finnish (NFE)
AF:
0.0741
AC:
80112
AN:
1081446
Other (OTH)
AF:
0.0729
AC:
4322
AN:
59248
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.458
Heterozygous variant carriers
0
4356
8712
13068
17424
21780
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3068
6136
9204
12272
15340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.111
AC:
16870
AN:
152116
Hom.:
1276
Cov.:
32
AF XY:
0.108
AC XY:
8009
AN XY:
74400
show subpopulations
African (AFR)
AF:
0.212
AC:
8769
AN:
41444
American (AMR)
AF:
0.120
AC:
1837
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.0530
AC:
184
AN:
3470
East Asian (EAS)
AF:
0.0519
AC:
269
AN:
5186
South Asian (SAS)
AF:
0.0383
AC:
185
AN:
4826
European-Finnish (FIN)
AF:
0.0375
AC:
397
AN:
10598
Middle Eastern (MID)
AF:
0.0374
AC:
11
AN:
294
European-Non Finnish (NFE)
AF:
0.0734
AC:
4991
AN:
68004
Other (OTH)
AF:
0.0882
AC:
186
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
743
1486
2229
2972
3715
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
168
336
504
672
840
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0801
Hom.:
198
Bravo
AF:
0.124
Asia WGS
AF:
0.0600
AC:
210
AN:
3478
EpiCase
AF:
0.0685
EpiControl
AF:
0.0644

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jul 09, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Emery-Dreifuss muscular dystrophy 5, autosomal dominant Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not specified Benign:1
Aug 15, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.46
CADD
Benign
10
DANN
Benign
0.81
PhyloP100
0.89
Mutation Taster
=215/85
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs33976862; hg19: chr14-64408852; COSMIC: COSV58359815; API